Rating Change
Barclays analysts downgraded Healthpeak Properties, Inc. (NYSE:DOC) from Overweight to Equal-Weight on July 07, 2026.
Rating Change Barclays analysts downgraded Healthpeak Properties, Inc. (NYSE:DOC) from Overweight to Equal-Weight on July 07, 2026. Market Context Healthpeak Properties, Inc.

Barclays analysts downgraded Healthpeak Properties, Inc. (NYSE:DOC) from Overweight to Equal-Weight on July 07, 2026.
Healthpeak Properties, Inc. operates in the Real Estate sector. The stock currently trades at $22.01 with a market capitalization of $11.6B. The stock has gained 21.7% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Barclays's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 07, 2026 | Barclays | Equal-Weight | N/A |
| Jul 06, 2026 | Mizuho | Outperform | N/A |
| Jun 24, 2026 | JP Morgan | Neutral | N/A |
| Jun 17, 2026 | Raymond James | Market Perform | N/A |
| Jun 15, 2026 | BMO Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View DOC Stock Page
A Equal-Weight rating from Barclays reflects the analyst's outlook on Healthpeak Properties, Inc. (NYSE:DOC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DOC forecast page.
Current market data
NYSE · DOC
$20.79
Down: -$0.02 · -0.10%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
earnings ·